An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients

Baird, Richard D.; Banks, Ian; Cameron, David; Chester, John D.; Earl, Helena; Flannagan, Mark; Januszewski, Adam; Kennedy, Richard D.; Payne, Sarah; Samuel, Emlyn; Taylor, Hannah; Agarwal, Roshan; Ahmed, Samreen; Archer, Caroline; Board, Ruth; Carser, Judith; Copson, Ellen; Cunningham, David; Coleman, Rob; Dangoor, Adam; Dark, Graham; Eccles, Diana; Gallagher, Chris; Glaser, Adam; Griffiths, Richard W.; Hall, Geoff; Hall, Marcia; Harari, Danielle; Hawkins, Michael M.; Hill, M; Johnson, Peter; Jones, Alison; Kalsi, Tania; Karapanagiotou, Eleni; Kemp, Zoe; Mansi, Janine; Marshall, Ernie; Mitchell, Alex J.; Moe, Maung; Michie, Caroline O.; Neal, Richard D; Newsom-Davis, Tom; Norton, Alison; Osborne, Richard; Patel, Gargi; Radford, John; Ring, Alistair; Shaw, Emily; Skinner, Rod; Stark, Dan; Turnbull, Sam; Velikova, Galina; White, Jeff; Young, A.; Joffe, Johnathan; Selby, Peter J.

doi:10.3332/ecancer.2016.608

Cited by 6 publications

(5 citation statements)

References 123 publications

(128 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the same study, investigators also reported substantial differences in the ratio of new cancer cases (incidence) versus the number of medical oncologists available in 2008 among participating countries; it was lowest in Hungary (113), Austria (125) and Sweden (136) and highest in the UK (1067) [18]. The Association of Cancer Physicians recently acknowledged a shortage of medical oncologists in the UK [19]. Although the ratio of 1 medical oncologist/100 000 population is standard in other WECs, this goal still needs to be achieved in the UK [20].…”

Section: Discussionmentioning

confidence: 88%

Medical Oncology Workload in Europe: One Continent, Several Worlds

et al. 2020

View full text Add to dashboard Cite

Aims: The workload pressure on medical oncologists will increase in the near future. There are no comprehensive data available about the current workload of medical oncologists in Europe. Here we report the European results of a global survey of the workload of medical oncologists. Materials and methods: An online survey was distributed through a snowball method via national oncology societies to chemotherapy-prescribing physicians in 21 European countries. We compared the workload of medical oncologists in Eastern European countries (EECs) and Western European countries (WECs). The primary measure of workload was the annual number of new cancer patient consults seen per oncologist. Results: In total, 495 oncologists from 16 European countries completed our survey: 100 from seven EECs and 395 from nine WECs. The median number of annual consults per medical oncologist was 225 in EECs compared with 175 in WECs (P < 0.001). The proportion of medical oncologists seeing more than 300 consults/year was 35% (35/100) in EECs compared with 18% (68/395) in WECs. The median number of patients seen in a full day clinic was 25 in EECs and 15 in WECs (P < 0.001). Eastern European medical oncologists reported spending a median of 25 min per new consultation compared with 45 min in WECs (P < 0.001). The top two reported barriers in both EECs and WECs to patient care were high clinical volumes and insufficient time for reading. Conclusion:The clinical workload of medical oncologists in EECs was substantially higher than in WECs. European health policymakers and educators need to address existing disparities in the workload of medical oncologist, undertake plans for future workforce supply and consider alternative models of care.

show abstract

Section: Discussionmentioning

confidence: 88%

Medical Oncology Workload in Europe: One Continent, Several Worlds

et al. 2020

View full text Add to dashboard Cite

show abstract

“…It is not necessary for all oncologists to have expert knowledge of all areas of cancer genomics. The three-tiered approach to oncogenetics training recommended by the ACP OTWP 27 envisages three levels of expertise: > For all medical oncologists: a comprehensive understanding of basic genomics, including limitations of current technology, key differences between somatic and germline mutations, and principles of stratified cancer medicine. > Practical experience in cancer genetics clinics for those who are interested, with the aim of providing medical oncologists who will be able to offer enhanced germline genetic advice in a multidisciplinary team (MDT) meeting setting.…”

Section: Formal Teaching Course a Bmentioning

confidence: 99%

Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists

et al. 2023

Self Cite

View full text Add to dashboard Cite

Genomics is rapidly changing treatment paradigms for cancers, obligating oncologists to have good genomics knowledge. Through this survey, we aimed to assess the current understanding of cancer genomics among UK oncologists. MethodsWe conducted a web-based nation-wide self-assessment survey of the cancer genomics knowledge of UK clinical and medical oncology trainees and consultants. ResultsIn total, 150 oncologists (81 consultants and 69 trainees) responded, representing 10% of UK oncologists.Formal training in genomics had not been received by 38.7% of oncologists and 92.7% identified a need for additional genomics training.In total, 71.3% self-reported to have good knowledge of defining somatic and germline mutations, falling to 35.3% for understanding principles of gene expression and regulation. Knowledge of cancer-predisposing syndromes was highest for Lynch syndrome (40.7% good knowledge) and lowest for multiple endocrine neoplasia (14.0% good knowledge).Overall, 49.0% of respondents had consented patients for germline testing, but 80.7% reported a lack of training in genetic counselling. Conclusion Large knowledge gaps have been identified through this survey, highlighting the need for incorporation of improved formal training in cancer genomics for consultants and trainees, with

show abstract

“…Systemic anti-cancer therapies are increasingly targeted against aberrant proteins associated with key driver mutations within the tumour (somatic) genome, requiring testing for, and identification of, such alterations in tumour-derived DNA to confer eligibility for treatment. 1 Falling sequencing costs have also driven expansion in testing for constitutional (germline) variants in cancer susceptibility genes (CSGs), which may inform surgical, systemic and radio-therapeutic options, as well as future cancer risks for patients and their relatives. 2 NHS England's publication of genomic test directories for cancer and rare and inherited disease, (including heritable cancer syndromes), aims to improve patients' access to genomic tests while streamlining testing processes.…”

Section: Introductionmentioning

confidence: 99%

GeNotes: a new online ‘just in time’ genomics resource for healthcare professionals

Copson

McVeigh

Frost

et al. 2022

Future Healthcare Journal

Self Cite

View full text Add to dashboard Cite

principles and technologies. All genomic test information is linked to appropriate pages of the NHS genomic test directories. 3,4 Sections on resources for clinicians and patients signpost key references and additional educational resources.Resources are reviewed by oncogenomics experts prior to uploading onto a purpose-built platform. Private beta phase testing (moderated usability testing, feedback questionnaire, follow-up interviews and website analytics review) of the first wave of resources was completed in November 2021 by Lagom Strategy.

show abstract

An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients

Abstract: The Association of Cancer Physicians in the United Kingdom has developed a strategy to improve outcomes for cancer patients and identified the goals and commitments of the Association and its members.

Cited by 6 publications

References 123 publications

Medical Oncology Workload in Europe: One Continent, Several Worlds

Medical Oncology Workload in Europe: One Continent, Several Worlds

Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists

GeNotes: a new online ‘just in time’ genomics resource for healthcare professionals

Contact Info

Product

Resources

About